1. Home
  2. APRE vs CETY Comparison

APRE vs CETY Comparison

Compare APRE & CETY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aprea Therapeutics Inc.

APRE

Aprea Therapeutics Inc.

HOLD

Current Price

$0.88

Market Cap

10.6M

Sector

Health Care

ML Signal

HOLD

Logo Clean Energy Technologies Inc.

CETY

Clean Energy Technologies Inc.

HOLD

Current Price

$0.79

Market Cap

9.9M

Sector

Utilities

ML Signal

HOLD

Company Overview

Basic Information
Metric
APRE
CETY
Founded
2006
1993
Country
United States
United States
Employees
8
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Power Generation
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
10.6M
9.9M
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
APRE
CETY
Price
$0.88
$0.79
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$4.10
N/A
AVG Volume (30 Days)
448.0K
122.7K
Earning Date
05-13-2026
05-19-2026
Dividend Yield
N/A
N/A
EPS Growth
21.22
N/A
EPS
N/A
N/A
Revenue
N/A
$957,633.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.55
$0.18
52 Week High
$2.22
$3.05

Technical Indicators

Market Signals
Indicator
APRE
CETY
Relative Strength Index (RSI) 55.83 45.58
Support Level $0.90 $0.79
Resistance Level $0.98 $0.85
Average True Range (ATR) 0.10 0.05
MACD 0.01 -0.00
Stochastic Oscillator 56.18 19.52

Price Performance

Historical Comparison
APRE
CETY

About APRE Aprea Therapeutics Inc.

Aprea Therapeutics Inc is a clinical-stage precision medicine oncology company focused on the discovery and development of targeted therapies for patients with biomarker-defined cancers. It develops small molecule inhibitors designed to exploit genetic mutations in cancer to widen the therapeutic window and is intended to make treatments more effective at destroying cancer cells while sparing healthy tissue. The company's pipeline of clinical and preclinical programs includes APR-1051, a WEE1 inhibitor; ATRN-119 (Mosipasertib), an oral small molecule inhibitor of ataxia telangiectasia and Rad3-related, or ATR; and an early-stage program, APR-1602. These candidates are being developed for broad applications in cancer treatment.

About CETY Clean Energy Technologies Inc.

Clean Energy Technologies Inc is clean energy and environmentally sustainable technologies company offering heat recovery solutions products. In addition, it also provides engineering and manufacturing solutions focused on other energy-efficient and environmentally sustainable technologies. The company's principal product is the Clean Cycle generator, offered by Heat Recovery Solutions. The company's engineering and manufacturing resources support its heat recovery solutions business. It has four segments: Clean Energy HRS & CETY Europe, CETY Renewables Waste to Energy Solutions, Engineering and Manufacturing Business and CETY HK. It serves various markets, including industrial, aerospace, military, instrumentation, and medical.

Share on Social Networks: